Study to Assess the Safety and Effects of Cells Injected Intravitreal in Dry Macular Degeneration

NCT02024269 · clinicaltrials.gov ↗
NA
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Bioheart, Inc.